ABSTRACT NUMBER: ESOC2026A341 ARGATROBAN PLUS ANTIPLATELET THERAPY VERSUS ANTIPLATELET ALONE IN ACUTE ISCHEMIC STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS WITH GRADE ASSESSMENT
Ahmed W Abbas, Rashad G Mohamed, Yousef Hawas, Mohamed Ellebedy, Mohamed F Abo-Elsoad, Magdy Shehab, Amir Hegazi, Hussien Hussien, Sarah Amro, Kareem Khalefa, Moaz Abouelmagd, Muataz Kashbour · 2026
Read ABSTRACT NUMBER: ESOC2026A341 ARGATROBAN PLUS ANTIPLATELET THERAPY VERSUS ANTIPLATELET ALONE IN ACUTE ISCHEMIC STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS WITH GRADE ASSESSMENT by Ahmed W Abbas, Rashad G Mohamed, Yousef Hawas, Mohamed Ellebedy, Mohamed F Abo-Elsoad, Magdy Shehab, Amir Hegazi, Hussien Hussien, Sarah Amro, Kareem Khalefa, Moaz Abouelmagd, Muataz Kashbour (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146238.txt.
Description
Ahmed W Abbas and co-authors present a 2026 conference review that pools past trials of a blood thinning drug added to standard care for acute stroke. The drug, argatroban, blocks a key clotting factor. Standard care alone uses drugs that stop platelets from clumping, and its effect is limited.
The review pooled eighteen studies with more than eleven thousand patients in total. Adding the drug raised the share of patients who recovered well and cut early decline in brain function. Scores for stroke severity also improved a bit more with the added drug. Bleeding risk and death rates did not rise, though the authors call for larger strict trials.
Catalog record
| CREATOR | Ahmed W Abbas, Rashad G Mohamed, Yousef Hawas, Mohamed Ellebedy, Mohamed F Abo-Elsoad, Magdy Shehab, Amir Hegazi, Hussien Hussien, Sarah Amro, Kareem Khalefa, Moaz Abouelmagd, Muataz Kashbour |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |